מדינה: ישראל
שפה: עברית
מקור: Ministry of Health
PARICALCITOL 4 MCG
ABBVIE BIOPHARMACEUTICALS LTD, ISRAEL
H05BX02
CAPSULES
PER OS
ABBVIE LTD, UK
PARICALCITOL
Zemplar is indicated for the prevention and treatment of secondary hyperparathyroidism associated with chronic renal insufficiency (chronic kidney disease stage 3 and 4 ) patients and chronic renal failure (chronic kidney disease stage 5) patients on haemodialysis or peritoneal dialysis.
2009-07-01